Subscribe

Model of Kantarjain et al for Predicting Induction Mortality and Overall Survival in a Patient >= 65 Years Old Treated with Intensive Chemotherapy for Acute Myelogenous Leukemia or High-Risk Myelodysp

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Kantarjian et al identified prognostic factors for a patient >= 65 years of age treated with intensive chemotherapy for acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). These can determine the chances of achieving a complete response. The authors are from the University of Texas M.D. Anderson Cancer Center.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone